GL1X · GenesisL1 explorer

MolNFT v1 · #158060 · protein

Crystal structure of a human anti-zikv-denv neutralizing antibody MZ4 in complex with zikv E glycoprotein

6NIU · Human MZ4 Fab heavy chain: “Crystal structure of a human anti-zikv-denv neutralizing antibody MZ4 in complex with zikv E glycoprotein”. X-ray diffraction, 20 pockets (best druggability 0.73). MolNFT v1 #158060 on GenesisL1: 3D…

PDB
6NIU
Type
protein
Length
2,520 residues
Chains
12
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Human MZ4 Fab heavy chain; Human MZ4 Fab light chain; Envelope protein E
UniProt
A0A024B7W1
Pockets
20 · best druggability 0.73

Structure

x-ray diffraction · 3 distinct chains · 6% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
H, F, I, MHuman MZ4 Fab heavy chainprotein1203% helix, 47% strand—
L, G, J, NHuman MZ4 Fab light chainprotein1113% helix, 46% strand—
B, A, Z, EEnvelope protein Eprotein3998% helix, 45% strandA0A024B7W1

Pockets

20 pockets found on a 1 Å grid, 14 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17220.730.7973empty
24700.720.8272empty
37480.700.7775empty
44310.680.8053empty
54360.670.7965empty

Interfaces

16 interfaces between chains.

  • Z–E · 1624 Ų buried · 11 hydrogen bonds · protein-protein
  • B–A · 1601 Ų buried · 21 hydrogen bonds · protein-protein
  • F–G · 1037 Ų buried · 10 hydrogen bonds · protein-protein
  • I–J · 1017 Ų buried · 13 hydrogen bonds · protein-protein
  • M–N · 1012 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 32 disulfide (disulfide).

Compared structures

  • 6NIU · Crystal structure of a human anti-ZIKV-DENV neutralizing antibody MZ4 in complex with… · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.